S Kant Healthcare Ltd.
Swarnlata Dakua is an accomplished pharmaceutical professional with extensive experience in research and development. Currently serving as Senior Scientific Group Leader at S Kant Healthcare Ltd. since February 2017, Swarnlata has held multiple leadership positions including Group Leader and Deputy Group Leader. Prior roles include time at Shalina Healthcare and RAPTAKOS BRETT & CO., where Swarnlata advanced from Junior Research Executive to Executive F&D. Educational qualifications include ongoing PhD studies in Pharmaceutical Sciences at Uka Tarsadia University, a Postgraduate Degree in Product Management and Analytics from Great Lakes Institute of Management, and a Master’s degree in Pharmaceutical Biotechnology from Biju Patnaik University of Technology, among other credentials in drug design and pharmacy.
This person is not in any teams
S Kant Healthcare Ltd.
S Kant Healthcare Ltd. is part of the SK Group, serving the pharmaceutical industry since 1932. Group Companies include Anuh Pharma Ltd., SK Logistics, Skites Pharma, Eskay Specialty Chemicals & Eskay Iodine. The EU-GMP Certified manufacturing facility is based in Vapi, India and has capabilities for oral solids, semi solids & oral liquid manufacturing. The company also manufactures anti malarial APIs, wound care API & Metallic stearates. It is backed by a state-of-the-art R&D Center in Navi Mumbai. Along with EU-GMP, the site is approved by various ministries of health and institutional agencies for essential medicines developed & manufactured by S Kant. Today, S Kant Healthcare serves as a CMO Partner for multiple MA Holders in Europe as well as Multi Nationals for India. The S Kant family consists of 550 members who strive to be a preferred manufacturer of quality medicines !